SDC1 and COVID-19: Regarding circulating effector B cells, it was found that COVID-19 patients had upregulated level of Ki67 marker as well as surface activation marker CD95 in circulating CD27+CD38+CD138+ B cells that might suggest about recent emigration from germinal center of the secondary lymphoid tissues [22].